NCT06174935尚未招募2 期
Low Dose Atropine For Symptomatic Vitreous Floaters
Jeanette Du1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年1月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Symptom improvement assessed by questionnaire
研究概览
简要总结
The objective of this study is to identify a potential pharmacologic option by assessing whether 0.01% atropine may be effective for treating bothersome floaters as measured by scores on a modified NEI VFQ-25.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients within Prism Vision Group with ICD diagnosis of acute posterior vitreous detachment and none of the ocular comorbidities listed as exclusion criteria will be screened as potential study participants.
排除标准
- •Patients with vitreous hemorrhage, other significant media opacity or vitreoretinal pathology, or history of pars plana vitrectomy will be excluded.
研究组 & 干预措施
Atropine 0.01%
Experimental
Patients will apply 1 drop daily of atropine 0.01%
干预措施: 0.01% atropine ophthalmic drop (Drug)
结局指标
主要结局
Symptom improvement assessed by questionnaire
时间窗: Up to 2 months
NEI VFQ-25 = National Eye Institute Visual Function Questionnaire
次要结局
未报告次要终点
研究者
Jeanette Du
Physician
Prism Vision Group
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Low-Dose Atropine for Treatment of MyopiaMyopiaNCT03334253Jaeb Center for Health Research200
尚未招募
4 期
Efficacy Comparison of 2 Low-dose Atropine Eye Drops in Vietnamese Children Myopia ManagementMyopiaNCT05803863University of Medicine and Pharmacy at Ho Chi Minh City108
招募中
3 期
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia ProgressionMyopia ProgressionMyopiaNCT06708156Oupushifang Pharmaceutical Technology Co., Ltd.606
招募中
1 期
Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia ControlMyopiaNCT06523504Ruihua Wei410
已完成
不适用
The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical TrialHigh MyopiaNCT04699357Shanghai Eye Disease Prevention and Treatment Center219